115 related articles for article (PubMed ID: 7901435)
1. Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
Okubo H; Yasue H; Ogawa H; Misumi I; Masuda T; Miyao Y; Sakamoto T
Jpn Circ J; 1993 Oct; 57(10):947-54. PubMed ID: 7901435
[TBL] [Abstract][Full Text] [Related]
2. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
[TBL] [Abstract][Full Text] [Related]
3. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
4. Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina.
Miyamoto S; Ogawa H; Sakamoto T; Soejima H; Takazoe K; Shimomura H; Kajiwara I; Yoshimura M; Kugiyama K; Nakamura S; Ozaki Y
Int J Cardiol; 2001; 80(2-3):235-42. PubMed ID: 11578720
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
[TBL] [Abstract][Full Text] [Related]
6. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
Suefuji H; Ogawa H; Yasue H; Imoto N; Sakamoto T; Miyao Y; Kaikita K; Soejima H; Nishiyama K
Coron Artery Dis; 1996 Feb; 7(2):167-72. PubMed ID: 8813450
[TBL] [Abstract][Full Text] [Related]
7. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
Xiong X; Zhao S; Wang Z; Lo L; Huang Q
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
[TBL] [Abstract][Full Text] [Related]
9. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.
Zalewski A; Shi Y; Nardone D; Bravette B; Weinstock P; Fischman D; Wilson P; Goldberg S; Levin DC; Bjornsson TD
Circulation; 1991 May; 83(5):1685-91. PubMed ID: 1902406
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease.
García Frade LJ; Alvarez JJ; Rayo I; Torrado MC; Lasunción MA; García Avello A; Hernandez A; Marín E
Thromb Res; 1991 Aug; 63(4):407-18. PubMed ID: 1836682
[TBL] [Abstract][Full Text] [Related]
11. Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment.
Huber K; Resch I; Rosc D; Probst P; Kaindl F; Binder BR
Thromb Res; 1989 Sep; 55(6):779-84. PubMed ID: 2506671
[TBL] [Abstract][Full Text] [Related]
12. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
Oshima S; Uchida K; Yasu T; Uno K; Nonogi H; Haze K
Arterioscler Thromb; 1991; 11(6):1772-7. PubMed ID: 1834167
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina.
Wieczorek I; Ludlam CA; Fox KA
Am J Cardiol; 1994 Sep; 74(5):424-9. PubMed ID: 8059719
[TBL] [Abstract][Full Text] [Related]
14. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Jia XQ; Dong CM; Qin J; Zhang L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
[TBL] [Abstract][Full Text] [Related]
15. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
[TBL] [Abstract][Full Text] [Related]
16. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium.
Munkvad S; Jespersen J; Gram J; Kluft C
J Intern Med; 1990 Oct; 228(4):361-6. PubMed ID: 1702458
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients.
Vucković BA; Djerić MJ; Ilić TA; Canak VB; Kojić-Damjanov SLj; Zarkov MG; Cabarkapa VS
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():12-7. PubMed ID: 20229676
[TBL] [Abstract][Full Text] [Related]
18. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic variables in postmenopausal women with unstable coronary artery disease.
Nielsen NE; Logander E; Swahn E
J Thromb Thrombolysis; 2001 Dec; 12(3):217-23. PubMed ID: 11981104
[TBL] [Abstract][Full Text] [Related]
20. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.
Munkvad S; Gram J; Jespersen J
Eur Heart J; 1990 Jun; 11(6):525-8. PubMed ID: 2112469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]